Work

62156 Maintenance of stringent clinical responses with bimekizumab in patients with axial spondyloarthritis: 2-year outcomes from two phase 3 studies

Year: 2025

Type: article

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2025.05.257

Authors: Alice B. Gottlieb, Fabian Proft, Désirée van der Heijde, Sergio Schwartzman, Joerg Ermann, Alexander Marten, Vanessa Taieb, Diana Voiniciuc, Victoria Navarro-Compán, Xenofon Baraliakos

Institutions: Icahn School of Medicine at Mount Sinai, Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, Leiden University Medical Center, Hospital for Special Surgery, NewYork–Presbyterian Hospital, Weill Cornell Medical Center, Brigham and Women's Hospital, Harvard University, UCB Pharma (Germany), UCB Pharma (France), UCB Pharma (United Kingdom), Hospital Universitario La Paz, Rheumazentrum Ruhrgebiet, Ruhr University Bochum

Language: English

Topic: Spondyloarthritis Studies and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413897041

FWCI:

Cites:

Cited by:

Related to: 10